文献速递流行病学与生物统计

22项针对同一问题的Meta分析结果差异的若干原因解释

Several reasons explained the variation in the results of 22 meta-analyses addressing the same question.
PubMed 文献 · J Clin Epidemiol · 2019-05-29

该研究纳入关于植入型心律转复除颤器(ICD)用于非缺血性心肌病患者的系统评价及其试验,评估22项Meta分析合并效应估计值之间的差异并调查原因。22项合并效应估计值与其中位值的绝对差异百分比平均为3.2%。结论认为,观察到的差异很少会导致临床医生或指南制定机构采取不同行动,差异最常与试验合格性和分析方法的错误及变异有关。

要点

  • 22项Meta分析合并效应估计值与中位值的绝对差异百分比平均为3.2%。
  • 差异原因包括试验纳入或排除决策不同(n=3)、分析方法差异(n=6)、Meta分析实施错误(n=5)及原因不明(n=1)。
  • 观察到的差异很少会导致临床医生或指南制定机构采取不同行动。

核心结论

  • 22项Meta分析结果之间观察到的差异很少会导致临床医生或指南制定机构采取不同行动。
  • 差异最常与试验合格性和分析方法的错误及变异有关。

研究设计与样本

  • 纳入关于植入型心律转复除颤器(ICD)用于非缺血性心肌病患者的系统评价及其纳入的试验。
  • 通过计算绝对差异百分比评估Meta分析合并效应估计值之间的变异。
  • 制定包含10条原因的清单,归纳为4个 overarching 类别。

主要发现

  • 识别21项系统评价,包括6项试验,报告22项符合条件的Meta分析。
  • 22项合并效应估计值(包括比值比、风险比、危险比)与其中位值的绝对差异百分比平均为3.2%。
  • 试验纳入或排除决策不同(n=3)。
  • 分析方法差异(n=6)。
  • Meta分析实施错误(n=5)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to assess and to investigate the reasons for the variations between the results of meta-analyses addressing the same question. STUDY DESIGN AND SETTING: We included systematic reviews, and the trials that they included, on the use of implantable cardiac defibrillator (ICD) in patients with nonischemic cardiomyopathy. We assessed the variation between meta-analyses pooled effect estimates by calculating the percentage of absolute difference. We developed a list of 10 reasons for variations between the results of the meta-analyses clustered in four overarching categories. RESULTS: We identified 21 systematic reviews including six trials and reporting on 22 eligible meta-analyses. The percentage of absolute difference between each of the 22 pooled effect estimates (included odds ratio, risk ratio, hazard ratio) and their median value had an average of 3.2%. The number of trials for which the following categories of reasons for variations applied were as follows: (1) different decision to include or exclude trials (n = 3); (2) differences in analytical approaches (n = 6); (3) errors in conducting meta-analyses (n = 5); and (4) unclear reason (n = 1). CONCLUSION: Few of the observed variations between the results of the 22 meta-analyses could lead clinicians or guideline development organizations to adopt different courses of actions. Variations were most frequently related to both errors and variations in trial eligibility and analytical approaches.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Khamis AM, El Moheb M, Nicolas J, et al. Several reasons explained the variation in the results of 22 meta-analyses addressing the same question. J Clin Epidemiol. 2019. PMID: 31150832. doi:10.1016/j.jclinepi.2019.05.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。